INNOVATE Corp. — Q1 2024 Form 10-Q
Reporting period: Three months ended March 31, 2024. INNOVATE is a diversified holding company with Infrastructure, Life Sciences and Spectrum segments, plus Other and Non-Operating Corporate activities. Amounts below are in millions unless stated otherwise.
Financial performance
| Metric | Q1 2024 | Q1 2023 |
|---|---|---|
| Revenue | $315.2 | $317.9 |
| Gross profit / gross margin | $48.6 / 15.4% | $43.6 / 13.7% |
| Operating income (loss) | $2.8 | $(4.0) |
| Interest expense | $17.2 | $15.6 |
| Net loss | $(20.1) | $(8.0) |
| Net loss attributable to common stockholders | $(17.7) | $(10.2) |
| Basic and diluted loss per share | $(0.22) | $(0.13) |
| Adjusted EBITDA (non-GAAP) | $12.8 | $4.9 |
| Cash used in operating activities | $(25.4) | $(77.0) |
| Capital expenditures | $5.6 | $3.7 |
Revenue declined $2.7 million year over year, primarily from Infrastructure project timing and size; Spectrum and Life Sciences partially offset the decline. Operating results improved by $6.8 million, mainly on higher gross profit and lower SG&A and depreciation and amortization. Net loss widened, in part because Q1 2023 included $16.1 million of gains related to the HMN investment, while Q1 2024 included a $2.2 million debt-extinguishment loss. Cash from operations improved, chiefly due to better Infrastructure working-capital movements.
Segments: Infrastructure revenue was $307.9 million and operating income was $9.3 million; Spectrum revenue was $6.3 million and operating income was $0.2 million; Life Sciences revenue was $1.0 million and operating loss was $3.2 million. Infrastructure backlog was $939.1 million at quarter end, including $402.7 million attributable to five projects. Remaining unsatisfied performance obligations were $925.2 million, expected to be recognized approximately over the next three years.
Financial position and liquidity
- Cash and cash equivalents were $38.4 million at March 31, down from $80.8 million at December 31, 2023. Consolidated cash, including restricted cash, declined $42.4 million during the quarter to $39.9 million.
- Current assets were $428.6 million and current liabilities were $349.0 million. Total assets were $943.5 million; total liabilities were $1,078.1 million. Stockholders’ deficit was $173.2 million.
- Consolidated debt principal was $687.0 million, down $35.8 million from year-end. The $330.0 million 8.50% senior secured notes due 2026 are the largest obligation. Debt fair value was estimated at $570.2 million versus carrying value of $674.8 million, excluding lease obligations.
- Cash used in financing was $12.9 million. The company reported $25.4 million of operating cash use and $3.3 million of investing cash use.
- Management said it expects to meet liquidity needs and fixed obligations for at least 12 months from issuance of the statements, relying on cash, subsidiary distributions and financing proceeds. It cautioned that distributions and additional financing or asset sales are subject to restrictions and are not assured.
Material developments, outlook and risks
- Equity financing: Lancer Capital, controlled by Chairman Avram Glazer, invested $25.0 million in Series C preferred stock on March 28. The rights offering closed April 24, issuing 5.3 million common shares for approximately $3.7 million; Lancer purchased a further approximately $6.3 million of Series C preferred stock. Gross proceeds from the offering and concurrent placement totaled $35.0 million. Proceeds are intended for general corporate purposes, including debt service and working capital.
- Dilution and control: Series C preferred stock is convertible at $0.70 per share subject to shareholder approval. Lancer’s beneficial ownership rose to 48.8% at March 31 and approximately 52.1% after the April transactions. If not converted, the preferred stock may be redeemed at the company’s option or on its sixth anniversary, with 8% annual uncompounded accretion payable upon redemption. Shareholder approval is expected to be sought at the 2024 annual meeting.
- Debt and refinancing: The company redeemed $4.1 million of its CGIC unsecured note on April 26 following the financing. That note’s interest rate rises from 9% to 16% beginning May 9, 2024, and to 32% beginning May 9, 2025. The corporate $20 million revolving facility maturity was extended after quarter end to May 16, 2025. R2 Technologies’ $20.7 million related-party note bears 20% interest and was extended to May 17, 2024; its exit fee was updated to 10.71% for repayments after May 1.
- Other unusual items: The $2.5 million Infrastructure note due March 31 was redeemed April 2. The company exited two leases with entities controlled by Mr. Glazer. On May 6, it terminated its Tax Benefits Preservation Plan.
- Risks and contingencies: High leverage, holding-company dependence on subsidiary distributions, covenant requirements, refinancing and capital-raising uncertainty, project cyclicality, labor and materials costs, and customer/project concentration remain important risks. Five Infrastructure projects account for 42.9% of backlog. The company reported compliance with debt covenants at March 31, but said future compliance may depend on cash management, asset monetizations, refinancing, or additional capital. Litigation includes DTV derivative claims scheduled for trial in February 2025 and a construction-related claim for which potential loss cannot be reasonably estimated; management believes the claims are without merit and does not expect pending matters to materially affect the financial statements.
No specific full-year revenue, earnings, or cash-flow guidance is provided in the filing. Management’s liquidity statement is an expectation, not assurance; it notes that additional financing may be unavailable on acceptable terms and could dilute common shareholders.
Most important facts for investors to verify
- Cash runway and corporate-level liquidity, including the timing and amount of cash distributions subsidiaries can make upstream.
- Debt maturities, interest-rate step-ups, covenant headroom, and refinancing or repayment plans—especially the CGIC note and R2 Technologies financing.
- Shareholder approval and conversion or redemption terms for Series C preferred stock, and the resulting dilution and Lancer ownership.
- Whether Infrastructure backlog converts to revenue as expected, given project timing, cancellation exposure, and concentration in five projects.
- Developments in DTV and construction litigation, and any changes to estimated exposure.